Related Experiment Video
Updated: Aug 16, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Management of intracranial hypertension
1Cleveland Clinic Foundation, Ohio.
Insights
Intracranial hypertension (ICH) management involves controlling aggravating factors and applying tailored therapies like hyperventilation or osmotic agents. Surgical intervention may be necessary for severe cases to reduce mortality.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Background:
- Intracranial hypertension (ICH) is a critical factor in neurological patient outcomes.
- Effective management of ICH is essential to prevent morbidity and mortality.
- Diverse neurological conditions can lead to ICH.
Purpose of the Study:
- To outline the therapeutic strategies for managing intracranial hypertension.
- To emphasize the importance of individualized treatment approaches for ICH.
- To discuss the role of conventional and surgical interventions in ICP reduction.
Main Methods:
- Review of established treatment protocols for intracranial hypertension.
- Analysis of factors that exacerbate elevated intracranial pressure (ICP).
- Evaluation of conventional therapies including hyperventilation, osmotic agents, sedatives, barbiturates, and CSF removal.
- Consideration of surgical options for refractory ICH.
Main Results:
- Initial ICP reduction focuses on controlling aggravating factors (e.g., body position, temperature, pain, blood pressure, seizures).
- Conventional therapies are selected based on individual patient clinical status and prognosis.
- Surgical mass removal is indicated for intractable ICH and significant brain shifts.
Conclusions:
- A heuristic, case-by-case application of therapeutic alternatives is crucial for managing ICH.
- Prompt identification and control of ICP-aggravating factors are paramount.
- Surgical intervention offers a vital option for severe, refractory intracranial hypertension.
Abstract:
Intracranial hypertension is the final common denominator of morbidity and mortality for diverse neurologic problems, and its proper treatment requires the heuristic application of the available therapeutic alternatives when the clinical situation and patient's prognosis warrants treatment. The initial therapeutic focus for ICP reduction should be control of factors that may aggravate intracranial hypertension such as inappropriate head and body position, elevated body temperature, pain, noxious stimuli, elevated airway pressure, elevated blood pressure, seizures, and hypotonic intravenous fluids. The appropriate conventional therapies (e.g., hyperventilation, osmotic agents, sedatives, barbiturates, and cerebrospinal fluid removal) should be selected based on the details of each individual case. Surgical removal of intracranial mass lesions may be indicated in some circumstances, particularly for intractable intracranial hypertension and progressive, severe brain tissue shifts.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Hypertension V: Nursing Management
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema l: Introduction

